Shifting weather patterns are altering the flowering seasons of plants that release allergenic pollen, says the report ...
A newly discovered mechanism renders antibiotic-resistant bacteria vulnerable by disabling both their individual resistance ...
New drugs approved in 2025 are poised to significantly improve the management of motion sickness, acute pain, urinary tract infections (UTIs), and chronic spontaneous urticaria. Gerald W. Smetana, MD, ...
AstraZeneca’s tozorakimab has shown benefit in a third Phase III trial in chronic obstructive pulmonary disorder (COPD). In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results